Distinct Metabolic Features of Seminoma and Embryonal Carcinoma Revealed by Combined Transcriptome and Metabolome Analyses
Authors:
- 5 March 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 18 (4) , 1819-1826
Abstract
Seminoma and embryonal carcinoma (EC), two typical types of testicular germ cell tumors (TGCTs), present significant differences in growth behavior, expression characteristics, differentiation potential, clinical features, therapy and prognosis. The purpose of this study was to compare the distinctive or preference metabolic pathways between seminoma and EC. The Cancer Genome Atlas revealed that many genes encoding metabolic enzymes could distinguish between seminoma and EC. Using well-characterized cell line models for seminoma (Tcam-2 cells) and EC (NT2 cells), we characterized their metabolite profiles using ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). In general, the integrated results from transcriptome and metabolite profiling revealed that seminoma and EC exhibited distinctive characteristics in the metabolisms of amino acids, glucose, fatty acids, sphingolipids, nucleotides, and drugs. Notably, attenuation of citric acid cycle/mitochondrial oxidative phosphorylation and sphingolipid biosynthesis, as well as increase of arachidonic acid metabolism and (very) long-chain fatty acids abundance occurred in seminoma as compared with EC. Our study suggests histologic subtype-dependent metabolic reprogramming in TGCTs and will lead to a better understanding of metabolic signatures and biology of TGCT subtypes.Keywords
Funding Information
- National Natural Science Foundation of China (31501198)
- The World Academy of Sciences
- Chinese Academy of Sciences
- China Association for Science and Technology (YESS20160118)
This publication has 52 references indexed in Scilit:
- Testicular germ cell tumor: a comprehensive reviewCellular and Molecular Life Sciences, 2019
- Integrated Molecular Characterization of Testicular Germ Cell TumorsCell Reports, 2018
- Future of testicular germ cell tumor incidence in the United States: Forecast through 2026Cancer, 2017
- Guidelines on Testicular Cancer: 2015 UpdateEuropean Urology, 2015
- Classification, epidemiology and therapies for testicular germ cell tumoursThe International Journal of Developmental Biology, 2013
- Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cellsGenes, Chromosomes and Cancer, 2012
- Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implicationsThe Journal of Pathology, 2008
- Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumorsProceedings of the National Academy of Sciences, 2003
- ESTABLISHMENT AND CHARACTERIZATION OF A NEW HUMAN TESTICULAR GERM CELL TUMOR CELL LINE (TCam-2)The Japanese Journal of Urology, 1993
- POSSIBLE CARCINOMA-IN-SITU OF THE TESTISThe Lancet, 1972